Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Article in British Journal of Cancer (April 2024)
The most recent citing publications are shown below. View all 171 publications that cite this research output on Dimensions.
Article in British Journal of Cancer (April 2024)
Article in Journal of Electroanalytical Chemistry (March 2024)
Article in Clinical Chemistry (January 2024)